Advisory Research’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-19,087
Closed -$1.45M – 374
2019
Q1
$1.45M Sell
19,087
-148,266
-89% -$11.8M 0.03% 210
2018
Q4
$12.2M Sell
167,353
-12,934
-7% -$1.03M 0.26% 104
2018
Q3
$17.3M Sell
180,287
-9,485
-5% -$940K 0.28% 91
2018
Q2
$19M Buy
189,772
+174,829
+1,170% +$18.5M 0.3% 88
2018
Q1
$1.58M Buy
14,943
+3,531
+31% +$357K 0.03% 228
2017
Q4
$1.06M Buy
11,412
+6,200
+119% +$563K 0.02% 271
2017
Q3
$472K Sell
5,212
-224
-4% -$19.1K 0.01% 366
2017
Q2
$457K Sell
5,436
-25,804
-83% -$2.08M 0.01% 372
2017
Q1
$2.52M Buy
+31,240
New +$2.46M 0.04% 221
2014
Q2
– Sell
-788
Closed -$68K – 435
2014
Q1
$68K Buy
+788
New +$64.6K ﹤0.01% 610

Other funds holding EMN

Advisory Research's EMN Position: Q2 2019 in Review

Advisory Research sold out of Eastman Chemical (EMN) in Q2 2019, closing a stake of 19,087 shares — an estimated $1.45M sold.

Advisory Research first reported a position in EMN in Q1 2014 and held it in 10 quarters. The position peaked at $19M in Q2 2018. 636 funds tracked by Wall St. Rank hold EMN as of Q2 2019.

  • Advisory Research reported no remaining Eastman Chemical position as of Q2 2019 after selling out during the quarter.
  • Advisory Research sold 19,087 Eastman Chemical shares in Q2 2019, an estimated $1.45M.
  • Advisory Research first reported a position in Eastman Chemical in Q1 2014 and held it in 10 quarters.
  • Advisory Research's Eastman Chemical position peaked at $19M in Q2 2018.
  • 636 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2019.

Based on Advisory Research's 13F filing for Q2 2019, filed 14 Aug 2019.